S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
S&P 500   4,002.87
DOW   32,560.60
QQQ   310.34
Game-Changing News For Tesla Investors 
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These 3 Stocks Are Ready To Rally Out Of Bullish Bases
Microsoft Is The New Safe Haven
Could This Be The Biggest Stock Of 2023? (Ad)pixel
These Are The Top 3 Large Caps For Yield And Dividend Growth 
A Guy Is Using ChatGPT to Turn $100 Into a Business Making as Much Money as Possible. Here Are the First 4 Steps the AI Chatbot Gave Him.
The Stock That Is Flying Under Wall St. Radar (Ad)pixel
DOW New Hghs Coming Sooner Than Later
On Holding AG Sprints Higher on Margin Expansion and Guidance
NYSE:ENFN

Enfusion - ENFN Stock Forecast, Price & News

$10.49
+0.34 (+3.35%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$10.22
$10.60
50-Day Range
$10.11
$12.10
52-Week Range
$7.80
$16.76
Volume
283,292 shs
Average Volume
457,704 shs
Market Capitalization
$1.21 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.79

Enfusion MarketRank™ Forecast

Analyst Rating
Hold
2.29 Rating Score
Upside/​Downside
10.4% Upside
$11.58 Price Target
Short Interest
Bearish
7.06% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.11mentions of Enfusion in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$11.43 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.03) to $0.01 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars

Computer And Technology Sector

522nd out of 601 stocks

Prepackaged Software Industry

179th out of 213 stocks


ENFN stock logo

About Enfusion (NYSE:ENFN) Stock

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Stock News Headlines

The Stock That Is Flying Under Wall St. Radar
With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!pixel
Why Enfusion Stock Surged Today
Enfusion Up 12% On Returning To Profit In Q4
The Stock That Is Flying Under Wall St. Radar
With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING!pixel
Enfusion, Inc. (ENFN) Q4 Earnings Match Estimates
Enfusion's Earnings: A Preview
Enfusion Names Oleg Movchan as Chief Executive Officer
Looking Into Enfusion's Return On Capital Employed
Enfusion Welcomes New Addition to Board of Directors
Enfusion Announces Resignation of Chief Financial Officer
Chief Revenue Officer of Enfusion Makes $355K Sale
See More Headlines
Receive ENFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enfusion and its competitors with MarketBeat's FREE daily newsletter.

ENFN Company Calendar

Last Earnings
3/07/2023
Today
3/21/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Prepackaged software
Sub-Industry
N/A
Fax
N/A
Employees
1,006
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$11.58
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$9.50
Forecasted Upside/Downside
+21.9%
Consensus Rating
Hold
Rating Score (0-4)
2.29
Research Coverage
6 Analysts

Profitability

Net Income
$-7,650,000.00
Pretax Margin
-8.11%

Debt

Sales & Book Value

Annual Sales
$150.35 million
Book Value
$0.91 per share

Miscellaneous

Free Float
69,048,000
Market Cap
$1.21 billion
Optionable
Not Optionable
Beta
0.49

Key Executives

  • Mr. Oleg Movchan (Age 49)
    CEO & Director
  • Mr. Stephen Malherbe
    Managing Partner
  • Mr. Bradley Herring (Age 52)
    Chief Financial Officer
  • Mr. Michael Berry
    Chief Operating Officer
  • Mr. Daniel Groman (Age 34)
    Chief Technology Officer
  • Mr. Brian Murphy
    Investor
  • Ms. Lorelei M. Skillman (Age 53)
    Chief Marketing & Communications Officer
  • Ms. Bronwen Bastone (Age 50)
    Chief People Officer
  • Mr. Kabir Kohli
    MD of Managed Services Solutioning & Global Head of Client Services
  • Mr. Joseph Defeo
    Global Head of Managed Services Production













ENFN Stock - Frequently Asked Questions

Should I buy or sell Enfusion stock right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Enfusion in the last year. There are currently 1 sell rating, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ENFN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ENFN, but not buy additional shares or sell existing shares.
View ENFN analyst ratings
or view top-rated stocks.

What is Enfusion's stock price forecast for 2023?

6 Wall Street research analysts have issued 12-month target prices for Enfusion's shares. Their ENFN share price forecasts range from $9.50 to $14.00. On average, they expect the company's share price to reach $11.58 in the next twelve months. This suggests a possible upside of 10.4% from the stock's current price.
View analysts price targets for ENFN
or view top-rated stocks among Wall Street analysts.

How have ENFN shares performed in 2023?

Enfusion's stock was trading at $9.67 on January 1st, 2023. Since then, ENFN stock has increased by 8.5% and is now trading at $10.49.
View the best growth stocks for 2023 here
.

Are investors shorting Enfusion?

Enfusion saw a drop in short interest in February. As of February 15th, there was short interest totaling 1,810,000 shares, a drop of 18.5% from the January 31st total of 2,220,000 shares. Based on an average daily volume of 372,900 shares, the short-interest ratio is presently 4.9 days. Currently, 7.1% of the company's stock are sold short.
View Enfusion's Short Interest
.

When is Enfusion's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our ENFN earnings forecast
.

How were Enfusion's earnings last quarter?

Enfusion, Inc. (NYSE:ENFN) announced its earnings results on Tuesday, March, 7th. The company reported $0.01 earnings per share (EPS) for the quarter. The business earned $40.52 million during the quarter, compared to the consensus estimate of $39.88 million. Enfusion had a negative net margin of 4.90% and a positive trailing twelve-month return on equity of 3.80%.

What ETFs hold Enfusion's stock?

ETFs with the largest weight of Enfusion (NYSE:ENFN) stock in their portfolio include Direxion Daily Cloud Computing Bull 2x (CLDL).Ranger Equity Bear ETF (HDGE).

What guidance has Enfusion issued on next quarter's earnings?

Enfusion issued an update on its FY 2023 earnings guidance on Wednesday, March, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $185.00 million-$190.00 million, compared to the consensus revenue estimate of $188.13 million.

When did Enfusion IPO?

(ENFN) raised $300 million in an initial public offering (IPO) on Thursday, October 21st 2021. The company issued 18,750,000 shares at a price of $15.00-$17.00 per share.

What is Enfusion's stock symbol?

Enfusion trades on the New York Stock Exchange (NYSE) under the ticker symbol "ENFN."

Who are Enfusion's major shareholders?

Enfusion's stock is owned by a variety of retail and institutional investors. Top institutional investors include Alliancebernstein L.P. (0.95%), New York State Common Retirement Fund (0.59%), Geode Capital Management LLC (0.31%), Bank of America Corp DE (0.17%), Franchise Capital Ltd (0.17%) and Charles Schwab Investment Management Inc. (0.12%). Insiders that own company stock include Dan Groman, Hillhouse Investment Managemen, Roy Luo, Stephen Malherbe and Tarek Hammoud.
View institutional ownership trends
.

How do I buy shares of Enfusion?

Shares of ENFN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Enfusion's stock price today?

One share of ENFN stock can currently be purchased for approximately $10.49.

How much money does Enfusion make?

Enfusion (NYSE:ENFN) has a market capitalization of $1.21 billion and generates $150.35 million in revenue each year. The company earns $-7,650,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does Enfusion have?

The company employs 1,006 workers across the globe.

How can I contact Enfusion?

The official website for the company is www.enfusion.com. The company can be reached via phone at 312-253-9800 or via email at brian.murphy@icrinc.com.

This page (NYSE:ENFN) was last updated on 3/22/2023 by MarketBeat.com Staff